Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: a Multicenter Randomized Trial (BURST-RAP Study)
BURST-RAP
1 other identifier
interventional
96
1 country
6
Brief Summary
Spinal cord stimulation (SCS) has shown to be an effective treatment for patients with persistent spinal pain syndrome Type 2 (PSPS Type 2). The method used to deliver electrical charge in SCS is important. One such method is burst stimulation. Two variations of burst waveforms are currently in use: one that employs active recharge and one that uses passive recharge. It is still unknown if there are clinical differences between active recharge and passive recharge burst SCS. To date, no clinical studies have been performed that directly compared these two burst stimulation waveforms. The objective of this Randomized Clinical Trial (RCT) is to assess and compare effect of passive recharge burst SCS with active recharge burst SCS on pain relief and motivational-emotional facets of pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2022
CompletedFirst Submitted
Initial submission to the registry
June 8, 2022
CompletedFirst Posted
Study publicly available on registry
June 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedNovember 19, 2024
November 1, 2024
3.9 years
June 8, 2022
November 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Pain catastrophizing score
6 months
Secondary Outcomes (9)
Numeric pain rating scale
3, 6, 12 months
Patient vigilance and awareness questionnaire
3, 6, 12 months
Hospital anxiety and depression scale
3, 6, 12 months
EQ-5D questionnaire
3, 6, 12 months
Oswestery disability index
3, 6, 12 months
- +4 more secondary outcomes
Study Arms (2)
Active recharge burst stimulation
EXPERIMENTALPassive recharge burst stimulation
EXPERIMENTALInterventions
Passive recharge burst is marked by a recharge pattern that passively compensates for charge differences.
Active recharge burst is characterized by negative pulses that directly compensate for charge differences.
Eligibility Criteria
You may qualify if:
- Subjects between 18 and 70 years of age
- At least moderate level of catastrophizing as measured with the Pain catastrophizing scale (PCS) of at least 20 at first visit of the pain clinic.
- Chronic pain diagnoses as PSPS Type 2 of at least 6 months
- Neurologic exam without marked motor deficit.
- LBP and/or leg pain intensity should be 5 or higher measured with the 11-box NRS 0-10
You may not qualify if:
- Subject has been screened by a multi-disciplinary panel including a psychologist and deemed suitable for implantation
- Subject is able and willing to comply with the follow-up schedule and protocol
- Subject is able to provide written informed consent
- Female subject of childbearing potential is pregnant/nursing or plans to become pregnant during the course of the study
- Escalating or changing pain condition within the past month as evidenced by investigator examination
- BMI ≥35
- "Subject has had injection therapy or radiofrequency treatment for their low back pain (LBP) or leg pain within the past 3 months"
- Subject currently has an active implantable device including ICD, pacemaker, spinal cord stimulator or intrathecal drug pump
- Subject is unable to operate the device
- Severe spinal column degeneration likely to cause technical problems with neuromodulation, to be assessed by the treating physician
- Previous Neurostimulation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Rijnstate Hospital
Arnhem, Gelderland, 6815 AD, Netherlands
Bravis Hospital
Roosendaal, North Brabant, 4708 AE, Netherlands
Elizabeth TweeSteden Hospital
Tilburg, North Brabant, 5042 AD, Netherlands
Amsterdam University Medical Hospitals A-UMC
Amsterdam, North Holland, 1105 AZ, Netherlands
Alrijne Hospital
Leiderdorp, South Holland, 2353 GA, Netherlands
Diakonessen Hospital
Zeist, Utrecht, 3707 HL, Netherlands
Related Publications (1)
Mons MR, Edelbroek C, Zuidema X, Burger K, Elzinga L, de Vries J, van Kuijk S, Joosten EA, Kallewaard JW. Study protocol: Effects of active versus passive recharge burst spinal cord stimulation on pain experience in persistent spinal pain syndrome type 2: a multicentre randomized trial (BURST-RAP study). Trials. 2022 Sep 5;23(1):749. doi: 10.1186/s13063-022-06637-7.
PMID: 36064598DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2022
First Posted
June 16, 2022
Study Start
February 16, 2022
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
November 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share